Skip to main content

Advertisement

Table 2 Showing the quality of different anti-malarials in different study communities

From: Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria

  Dihydroartemesinin
N = 4
n (%)
Quinine
N = 28
n (%)
Sulphadoxine-Pyrimethamine (SP)
N = 113
n (%)
Chloroquine
N = 56
n (%)
Artesunate
N = 24
n (%)
Total
N = 225
n (%)
Pass* 3 (75) 15 (54) 69 (61) 54 (96) 24 (100) 165 (73)
Fail* 1 (25) 13 (46) 44 (39) 2 (4) 0 (0) 60 (37)
Total 4 (100) 28 (100) 113(100) 56 (100) 24 (100) 225 (100)
Failures       
Public 0 (0) 2 (15) 9 (21) 2 (100) 0 (0) 13 (22)
Private 1 (100) 11 (85) 35 (79) 0 (0) 0 (0) 47 (78)
Total 1 (100) 13 (100) 44 (100) 2 (100) 0 (0) 60 (100)
Failures       
Low level 0 (0) 10 (77) 25 (57) 1 (50) 0 (0) 36 (60)
High/med 1 (100) 3 (23) 19 (43) 1 (50) 0 (0) 24 (40)
Total 1 (100) 13 (100) 44 (100) 2 (100) 0 (0) 60 (100)
  1. Note: A failure in the context of the study implies that the tablets did not meet the USP tolerance limits for quality test for active ingredient released during the dissolution test.